Zoetic International welcomes Paul Mendell to its Board of Directors as Non-Executive Chairman

– UK, London –  Zoetic International PLC (LON: ZOE), the London listed vertically integrated CBD and natural resources company, today announced that Paul Mendell has been appointed to the Board as Non-Executive Chairman.

Nick Tulloch, CEO, Zoetic International, said: “I am delighted to welcome Paul to his new role with us. Since we announced our new strategy two weeks ago, Paul has been an enormous support. He has an in-depth understanding of both sides of our business and, in particular, no one has as much knowledge of our natural resource assets, and of how to monetise them, like Paul. He is popular with our team and business partners and I am looking forward to working with him to deliver value to shareholders.”

“We have a new name, a new strategy and a refocussed management team. While we are under no illusion about the scale of the task ahead of us, we are confident that our CBD business can be built into a highly profitable operation and that during that period it can be supported by realising value from our natural resources assets,” he added.

About Paul Mendell

Mr. Mendell has been involved with the Company since its IPO and has been instrumental in both the identification of its natural resources projects as well as taking a lead role in establishing the CBD business, particularly by identifying the significant potential of Zoetic International’s nitrogen-hydrogen gas discovery in Kansas. He was also the co-founder of Iofina plc and, prior to a recent acquisition, owned interests in over 250 horizontal and vertical producing oil and gas wells in the US.

For more information: http://zoeticinternational.com

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.